BR0313076A - Sal de ácido orgânico de amlodipina - Google Patents

Sal de ácido orgânico de amlodipina

Info

Publication number
BR0313076A
BR0313076A BR0313076-2A BR0313076A BR0313076A BR 0313076 A BR0313076 A BR 0313076A BR 0313076 A BR0313076 A BR 0313076A BR 0313076 A BR0313076 A BR 0313076A
Authority
BR
Brazil
Prior art keywords
amlodipine
organic acid
acid salt
preparation
pharmaceutical composition
Prior art date
Application number
BR0313076-2A
Other languages
English (en)
Inventor
Seong-Hwan Cho
Yong-Sik Youn
Yun-Taek Jung
Choong-Sil Park
Hyun-Koo Lee
Kwang-Hyeg Lee
Eun-Ju Jeong
Young-Hoon Kim
Hae-Tak Jin
Jun-Hee Cheon
Sung-Hak Lee
Sung-Hak Jung
Dong-Kwon Lim
Kyu-Jeong Yon
Yun-Cheul Kim
Kyung-Mi Park
Hyun-Suk Kang
Original Assignee
Cj Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cj Corp filed Critical Cj Corp
Publication of BR0313076A publication Critical patent/BR0313076A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/86—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicinal Preparation (AREA)

Abstract

"SAL DE áCIDO ORGâNICO DE AMLODIPINA". São descritos um novo sal de ácido orgânico de amlodipina, seu método de preparação, e uma composição farmacêutica contendo o mesmo como um ingrediente terapeuticamente ativo.
BR0313076-2A 2002-07-30 2003-07-30 Sal de ácido orgânico de amlodipina BR0313076A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020020044856A KR20040011751A (ko) 2002-07-30 2002-07-30 암로디핀의 유기산염
PCT/KR2003/001522 WO2004011432A1 (en) 2002-07-30 2003-07-30 Organic acid salt of amlodipine

Publications (1)

Publication Number Publication Date
BR0313076A true BR0313076A (pt) 2005-06-28

Family

ID=31185754

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0313076-2A BR0313076A (pt) 2002-07-30 2003-07-30 Sal de ácido orgânico de amlodipina

Country Status (8)

Country Link
EP (1) EP1549616A4 (pt)
JP (1) JP2005538103A (pt)
KR (1) KR20040011751A (pt)
CN (1) CN1678583A (pt)
AU (1) AU2003247208A1 (pt)
BR (1) BR0313076A (pt)
MX (1) MXPA05001241A (pt)
WO (1) WO2004011432A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100913791B1 (ko) * 2006-07-21 2009-08-26 한미약품 주식회사 (ｓ)-(-)-암로디핀 캠실레이트 또는 이의 수화물 및 이를함유하는 약학적 조성물
KR100821688B1 (ko) 2006-08-10 2008-04-11 (주)유케이케미팜 암로디핀 라셈화물의 입체이성질체의 분리방법과 그의친수성 약물 및 그의 제조방법
RS55487B2 (sr) 2010-02-12 2024-06-28 Pfizer Soli i polimorfi 8-fluoro-2-{4-[(metilamino}metil]fenil}-1,3,4,5-tetrahidro-6h-azepino[5,4,3-cd]indol-6-ona
CN101972254B (zh) * 2010-09-28 2012-05-30 石药集团欧意药业有限公司 一种左旋氨氯地平或其可药用盐固体制剂及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK161312C (da) * 1982-03-11 1991-12-09 Pfizer Analogifremgangsmaade til fremstilling af 2-aminoalkoxymethyl-4-phenyl-6-methyl-1,4-dihydropyridin-3,5-dicarboxylsyreestere eller syreadditionssalte deraf samt phthalimidoderivater til anvendelse som udgangsmateriale ved fremgangsmaaden
GB8608335D0 (en) * 1986-04-04 1986-05-08 Pfizer Ltd Pharmaceutically acceptable salts
GB8710493D0 (en) * 1987-05-02 1987-06-03 Pfizer Ltd Dihydropyridines
US6057344A (en) * 1991-11-26 2000-05-02 Sepracor, Inc. Methods for treating hypertension, and angina using optically pure (-) amlodipine
KR100452491B1 (ko) * 2001-03-29 2004-10-12 한미약품 주식회사 신규한 결정형 암로디핀 캠실레이트 염 및 그의 제조방법

Also Published As

Publication number Publication date
EP1549616A1 (en) 2005-07-06
EP1549616A4 (en) 2006-10-18
MXPA05001241A (es) 2005-06-08
AU2003247208A1 (en) 2004-02-16
CN1678583A (zh) 2005-10-05
JP2005538103A (ja) 2005-12-15
WO2004011432A1 (en) 2004-02-05
KR20040011751A (ko) 2004-02-11

Similar Documents

Publication Publication Date Title
ATE469136T1 (de) Inhibitoren von 11-beta- hydroxysteroiddehydrogenase typ 1
NO20042161L (no) Inhibitorer av 11-beta-hydroksysteroid dehydrogenase type 1
SE0001899D0 (sv) New compounds
DK1475101T3 (da) Antistof-holdige farmaceutiske opløsninger
NO20065904L (no) Terapeutiske forbindelser
DE60334773D1 (de) Formulierungen zur oralen verabreichung von wirkstoffen
ECSP055528A (es) Composicion farmaceutica que tiene una distribución y potencia uniforme de farmaco
GB0222514D0 (en) Organic compounds
BR0111678A (pt) Composições medicinais contendo derivados de propenona
BR9916575A (pt) Composição farmacêutica de liberação controlada com mesilato de tilidina como substância-ativa
AU2002214389A1 (en) Pharmaceutical composition containing honey for the treatment of wounds
ATE486852T1 (de) Salze von 9-oxoacridin-10-essigsäure mit 1- alkylamino-1-desoxypolyolen
MXPA02012889A (es) Esteres de acidos 4-alcoxi-ciclohexano-1-amino-carboxilicos y procedimiento para su obtencion.
BR0317383A (pt) Metabólitos agonista de vasopressina biologicamente ativos
DK0634396T3 (da) Aminosyrederivater og deres anvendelse som enkeltfalinaseinhibitorer
BR0313076A (pt) Sal de ácido orgânico de amlodipina
HUP0600084A2 (en) Pharmaceutical compositions containing ascorbic acid derivatives, methods of production of the active ingredient
AU2003256108A1 (en) Organic acid salt of amlodipine
BR0311479A (pt) Derivados de tiofeno antelmìnticos e inseticidas
BR0303475A (pt) Sal cristalino do ácido adìpico da amlodipina, respectivo método de preparação e composição farmacêutica
NO20030021D0 (no) Heterosykliske forbindelser som er inhibitorer for enzymet DPP-IV
DE60003188D1 (de) Paracetamol und drotaverin enthaltende zusammensetzung
AP2003002897A0 (en) Processes and intermediates for preparing benzyl epoxides
DE60029946D1 (de) Arzneimittel gegen glomerulosclerose
EA200401082A1 (ru) Новые соединения бензоиндолина, способ их получения и фармацевтические композиции, которые их содержат

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: CJ CHEILJEDANG CORPORATION (KR)

Free format text: TRANSFERIDO DE: CJ CORPORATION

B15K Others concerning applications: alteration of classification

Free format text: PARA INT.CL: C07D 211/86, C07D 211/90, A61K 31/4422, A61K 9/08, A61K 9/20, A61K 9/48, A61K 43/00, A61P 9/10, A61P 9/12

Ipc: C07D 211/86 (2011.01)

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE A 9A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2162 DE 12/06/2012.